In patients with type 2 diabetes (T2D) on first-line glucagon-like peptide 1 (GLP-1) receptor agonist therapy, adding or switching to second-generation basal insulins (2BI) may greatly improve A1c and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback